… ’s disease pathophysiology beyond the deposition of amyloid-beta … a heterogeneous effect
on clinical Alzheimer’s disease … memory but also in neuropsychiatric symptoms that occur in …

… As a marker of small vessel cerebrovascular disease, WMH may be a measure of … participants
with vascular risk factors or vascular disease, less cerebral amyloid burden is necessary …

… cortex showing a distribution similar to that of amyloid-β plaques (CD68 antibodies, specific
… , especially regarding the neuropsychiatric symptoms. Longitudinal studies will be necessary …

… placebo-controlled crossover studies, is needed … diseases or symptoms of diseases.
Furthermore, the biological activity of the active compound(s) need to be confirmed by further studies…

… burden of small vessel disease in cerebral amyloid angiopathy: an imaging-pathologic
study of … Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive …

… of hypertensioninduced cerebral small vessel disease and the … We also discuss drugs to
treat cerebral small vessel disease … with hypertensive microvascular lesions, amyloid protein is …

… 摘要: 脑小血管病(cerebral small vessel disease, CSVD)可导致精神… Abstract: Cerebral small
vessel disease (CSVD) can lead to … role in neuropsychiatric disorders in patients with CSVD. …

… CMBs occur because of bleeding around small vessels, primarily seen in cerebral amyloid …
as a marker of cerebral small-vessel disease and cerebral amyloid angiopathy (Fu et al., 2013…

… There are various pathological hallmarks including the accumulation of extracellular amyloid
plaques composed of amyloid-β (Aβ) protein(3,4) and intracellular neurofibrillary tangles …

… hypothesis of Alzheimer’s disease and analyzing the possible implications of COVID-19 …
to the amyloid-β cascade and how it could lead to the pathological hallmarks of the disease. …